Audience -Adults & Aging-All Patients & Families-Chapters-Donors & Supporters-Healthcare Providers-Kids & Young Adults-Men-Payers-Spanish Speaking Individuals-Undiagnosed-Women & Girls Type of Bleeding Disorder -All Bleeding Disorders-Hemophilia-Inhibitors-Rare Bleeding Disorders-Von Willebrand Disease Topic -Advocacy-Awareness-Blood & Product Safety-Community-COVID-19-Diversity, Equity & Inclusion-Fitness & Nutrition-Future Therapies-Health Equity-Healthcare Insurance-HIV & Hepatitis C-Bone & Joint Health-Mental Health-Pain Management-Sexual & Reproductive Health-Research-Digital Health-Treatment & Care 10 Aug 50 Years of the JGP Research Fellowship Aug 10, 2022 - Aug 10, 2022 03 Aug Markers of autoimmunity in immune thrombocytopenia Aug 3, 2022 - Aug 3, 2022 20 Jul VWD and Iron Deficiency Jul 20, 2022 - Jul 20, 2022 13 Jul Quantitative measurements of hemophiliac joint tissues by point-of-care musculoskeletal ultrasound Jul 13, 2022 - Jul 13, 2022 29 Jun The Challenges of Assessing and Managing Pain Jun 29, 2022 - Jun 29, 2022 22 Jun Sickle Cell Disease & Red Blood Cell Transfusion Jun 22, 2022 - Jun 22, 2022 15 Jun Factor product utilization and health outcomes in patients with hemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes Jun 15, 2022 - Jun 15, 2022 08 Jun Lived experiences and barriers to care for men with hemophilia Jun 8, 2022 - Jun 8, 2022 01 Jun Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors Jun 1, 2022 - Jun 1, 2022 25 May Using Real World Data to Inform Clinical Research, featuring ATHN’s new Robust Health App May 25, 2022 - May 25, 2022 18 May Implementation Science May 18, 2022 - May 18, 2022 11 May Finding Financial Support May 11, 2022 - May 11, 2022 04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022 27 Apr AAV Antibodies Update Apr 27, 2022 - Apr 27, 2022 20 Apr Medical Marijuana 101 for the Inheritable Blood Disorder Community Apr 20, 2022 - Apr 20, 2022 13 Apr Whole 1 Exome Analysis of Adolescents with Low VWF and Heavy Menstrual Bleeding Identifies Novel Genetic Associations Apr 13, 2022 - Apr 13, 2022 06 Apr The effect of emicizumab prophylaxis on long‐term self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Apr 6, 2022 - Apr 6, 2022 30 Mar Shared Decision-Making: An Essential Element to Patient-Centricity Mar 30, 2022 23 Mar #Hemophilia: Lessons and Opportunities for Advocacy on Twitter Mar 23, 2022 16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022 09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022 23 Feb Rare Bleeding Disorders in the Plains Community Feb 23, 2022 - Feb 23, 2022 16 Feb Point of Care Coagulation Testing Using ClotChip Technology Feb 16, 2022 - Feb 16, 2022 09 Feb Advocating for Your Care in the Emergency Room Feb 9, 2022 - Feb 9, 2022 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Next page Last page
13 Jul Quantitative measurements of hemophiliac joint tissues by point-of-care musculoskeletal ultrasound Jul 13, 2022 - Jul 13, 2022
15 Jun Factor product utilization and health outcomes in patients with hemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes Jun 15, 2022 - Jun 15, 2022
01 Jun Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors Jun 1, 2022 - Jun 1, 2022
25 May Using Real World Data to Inform Clinical Research, featuring ATHN’s new Robust Health App May 25, 2022 - May 25, 2022
04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022
20 Apr Medical Marijuana 101 for the Inheritable Blood Disorder Community Apr 20, 2022 - Apr 20, 2022
13 Apr Whole 1 Exome Analysis of Adolescents with Low VWF and Heavy Menstrual Bleeding Identifies Novel Genetic Associations Apr 13, 2022 - Apr 13, 2022
06 Apr The effect of emicizumab prophylaxis on long‐term self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Apr 6, 2022 - Apr 6, 2022
16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022
09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022
